COMMUNIQUÉS West-GlobeNewswire

Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer

05/09/2019 - 14:30

NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing [...]

Cronos Group Inc. Closes Redwood Holding Group Acquisition

05/09/2019 - 14:30

TORONTO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has closed its previously announced acquisition of four Redwood [...]

Better Choice Company Announces Marketing Partnership with iHeartMedia

05/09/2019 - 14:27

NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (OTCQB: BTTR) (the “Company” or “Better Choice”), an animal health and wellness CBD company, today announced a new media partnership with [...]

American BriVision Announces Strategic Collaboration with BioLite Japan

05/09/2019 - 14:17

Collaboration combines BioLite Japan’s early-stage discovery capabilities with the Company’s clinical trial expertise BioLite Japan’s expertise in academic and medical community in Japan and APAC region brings new [...]

Catalyst Biosciences to Present at the 2019 ASBMB Symposium on Serine Proteases in Pericellular Proteolysis and Signaling Conference

05/09/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced an oral presentation at the 2019 American Society for Biochemistry and Molecular Biology (ASBMB [...]

VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference

05/09/2019 - 14:00

CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]

Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management

05/09/2019 - 14:00

ATLANTA, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal [...]

GBT Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Voxelotor for the Treatment of Sickle Cell Disease

05/09/2019 - 14:00

Priority Review Shortens FDA Review Time to Six Months from Standard 10 Months NDA Supported by Data from Phase 3 HOPE Study, which Demonstrated Statistically Significant and Sustained Improvements in Hemoglobin with [...]

Dr. Henry Ji to Participate in Multiple Investment Conferences in September 2019 to Provide Corporate Updates

05/09/2019 - 14:00

SAN DIEGO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in multiple investment conferences in September [...]

REPEAT: AgraFlora Organics Awarded YuShop Global Listing; To Fulfill Chinese Pre-Orders with Premium Hemp-Derived Cosmetics SKUs Via One of China’s Premier Cross-Border Lifestyle/E-Commerce Platform

05/09/2019 - 14:00

VANCOUVER, British Columbia, Sept. 05, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]

BioSig‘s Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million

05/09/2019 - 13:52

The Company to develop solutions to advance bioelectronic medicine Westport, CT, Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical [...]

Auxly Announces Receipt of Cannabis Research Licence to KGK Science

05/09/2019 - 13:30

VANCOUVER, British Columbia, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (“ Auxly ” or the “ Company ”) today announced that its wholly-owned subsidiary, KGK Science Inc. (“ KGK ”), has [...]

European Research Initiative Adopts PacBio Sequel II System to Solve Rare Diseases

05/09/2019 - 13:30

SOLVE-RD program will sequence more than 500 human genomes with SMRT Sequencing MENLO PARK, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high- [...]

KemPharm to Present at the 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co.

05/09/2019 - 13:30

CELEBRATION, Fla., Sept. 05, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that its president [...]

Wave Life Sciences Expands Board of Directors with Three New Appointments

05/09/2019 - 13:30

New independent directors bring deep expertise in drug development, commercial operations and government affairs CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical- [...]

Scholar Rock Announces Appointment of George Nomikos, M.D., Ph.D., as Vice President, Head of Medical Research, Muscle Franchise

05/09/2019 - 13:30

Highly experienced physician-scientist and drug developer to lead SRK-015 latent myostatin program CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage [...]

Solid Biosciences Announces Publication Highlighting the Important Role of the nNOS Domain in Microdystrophin Function and its Potential Utility in DMD Gene Therapy in the Journal Neuromuscular Disorders

05/09/2019 - 13:30

CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) today announced the publication of a review article in the journal Neuromuscular Disorders ¹ that summarizes the evidence [...]

Stemline Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference

05/09/2019 - 13:30

NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]

New Caregiver-Reported Data Further Validate the Use of the Aberrant Behavior Checklist Community: FXS Specific (ABC-CFXS) Subscales to Assess Core Behavioral Symptoms of Fragile X Syndrome (FXS)

05/09/2019 - 13:00

- Ninety Percent of Interviewed Caregivers Reported Social Avoidant, Irritability, and Socially Lethargic Behaviors in their Children with FXS - - New Data Presented Today at the Society for the Study of Behavioural [...]